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Abstract
Accelerometers and other wearable devices are increasingly being used in clinical trials to provide an objective
measure of the impact of an intervention on physical activity. Missing data are ubiquitous in this setting, typically for
one of two reasons: patients may not wear the device as per protocol, and/or the device may fail to collect data (e.g.
flat battery, water damage). However, it is not always possible to distinguish whether the participant stopped wearing
the device, or if the participant is wearing the device but staying still. Further, a lack of consensus in the literature on
how to aggregate the data before analysis (hourly, daily, weekly) leads to a lack of consensus in how to define a
“missing” outcome. Different trials have adopted different definitions (ranging from having insufficient step counts in
a day, through to missing a certain number of days in a week). We propose an analysis framework that uses wear time
to define missingness on the epoch and day level, and propose a multiple imputation approach, at the day level,
which treats partially observed daily step counts as right censored. This flexible approach allows the inclusion of
auxiliary variables, and is consistent with almost all the primary analysis models described in the literature, and readily
allows sensitivity analysis (to the missing at random assumption) to be performed. Having presented our framework,
we illustrate its application to the analysis of the 2019 MOVE-IT trial of motivational interviewing to increase exercise.
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Introduction
The use of pedometers, accelerometers and other devices
to measure physical activity in clinical trials has increased
rapidly in the last 20 years [1]. These tracking devices offer
step count and intensity of activity measurements in very
fine intervals of time, often in seconds, which removes
recall and desirability bias that come with measuring
activity using self-report approaches [2]. A number of
clinical trials have used accelerometers to measure change
in participants’ physical activity for a period of 7 days
before and after an intervention, possibly with additional
follow-up. The MOVE-IT trial measured participants’
activity for 7 days on three occasions: at baseline, after
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implementing group or individual motivational therapy,
and one year after the completion of therapy [3]. Other
trials with a similar structure in measurement period and
follow-up include the PACE-UP and PACE-LIFT trials,
which measured participants’ activity for 7 days before
and after implementation of a walking-based intervention
[4–6]. In the Trial of Activity in Adolescent Girls (TAAG),
effect of school- and community-based interventions on
physical activity in middle-school girls was measured by
accelerometers [7, 8]. A similar set-up was used in studies
investigating telephone-delivered interventions on lung
cancer patients [9] and diabetic patients [10].
The proportion of planned data that each participant
contributes varies due to a number of factors. Participants
may forget to wear the accelerometer and provide reduced
step counts for some days, and there are also protocol-
compliant reasons for removing the accelerometer, such
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when swimming or showering if the accelerometer is not
water proof [7]. There may also be technical issues such as
the battery running out, or the device failing if used acci-
dentally under water. Despite the ubiquity of missing data
in trials using accelerometer outcome data, there is cur-
rently little guidance on how to handle this in the analysis.
At a very fundamental level, there is currently no consen-
sus on the definition of missing data in this context [2].
Accelerometers record accelerations in three dimensions
over very fine intervals of time, called epochs. These accel-
erations can be processed to calculate the number of steps
taken. If zero accelerations are registered for a particu-
lar epoch, and especially for a large number of adjacent
epochs, it is not obvious whether the participant is wear-
ing the device and simply staying still, or whether the
device has been removed and no data is being collected.
When focusing on daily step counts, if a participant does
not wear the accelerometer for the entire day, this is clearly
an instance of missing data; less clear-cut is defining what
a sufficient amount of wear time of the accelerometer
should be, in order for the observation to be deemed a
complete daily step count observation. There are many
suggestions in the literature for how to define missing-
ness in terms of a threshold for daily step count or wear
time [10–12]. Further, if step counts from an insufficient
amount of time are provided, there is the question of
whether this data should be considered as censored data,
or whether those counts should be discarded and that day
should be considered missing. The two approaches lead to
different requirements in the analysis. The combination of
increased use of accelerometer data and a lack of guidance
in how to handle missing data in this context means that
there is a need to evaluate the various possible approaches
to handling missing data analysis and then derive a frame-
work which can be used to inform future trial designs,
protocols and statistical analysis plans.
If there are no missing data, analysis of repeated step
counts is typically conducted by a simple linear regres-
sion of step counts aggregated over the measurement
period. Multilevel modelling is also often useful when
the study is longitudinal or if there is clustering of par-
ticipants. A primary analysis of the trial generally has
average step counts over the measurement period (e.g.
average daily step counts over a pre-specified week) as
the outcome, which allows a straightforward compari-
son of average step counts pre- and post-intervention.
In contrast to daily step counts, which are bounded at
zero and typically mildly skewed, average step counts over
the measurement period are likely to be approximately
normal, making an analysis on the untransformed scale
sufficient. Supplementary analysis could include a mixed
model with daily step counts as the outcome, which allows
for the study of day-level variables such as day of the week
or weather.
When there are missing data, there are two commonly
used principled approaches of handling them. Firstly,
missing outcome data are easily handled by maximum
likelihood methods for linear regression or mixed models
under the missing at random (MAR) assumption [13, p.
56]. Under the MAR assumption, missingness depends on
the observed step counts and/or covariates included in the
primary analysis model; given these, it does not depend
on the unobserved pattern of step counts [7]. Now, a key
issue is that the MAR assumption may be implausible in
the accelerometer setting since it is quite likely that partic-
ipants do not wear their device during days or parts of days
where they are less active; an analysis that assumes that
data are MAR when it is not can lead to invalid estimates.
Alternatively, multiple imputation (MI) offers a flexi-
ble approach to the analysis of accelerometer data with
missing values. An imputation model is specified, which
is a model for the posterior predictive distribution of the
missing outcomes given the observed data; this is used to
impute the missing outcomes with plausible values, tak-
ing full account of the uncertainty [14]. A total of M sets
of complete data are constructed and the analysis model is
fitted to each of them. The results of theM analysis mod-
els are combined using Rubin’s rules to incorporate uncer-
tainty due to the missing data [15]. The imputation model
and the analysis model are separate; this feature is partic-
ularly appropriate in the accelerometer setting where the
primary analysis model may have averaged step counts as
the outcome, but missingness is defined for smaller inter-
vals of time, most typically for days, so constructing the
imputation model with daily step counts as the outcome
is a natural approach. It is possible to incorporate step
counts as right-censored observations with MI if partic-
ipants took an insufficient number of steps. MI typically
assumes MAR given the variables included in the imputa-
tion model; the imputation model may include additional
auxiliary variables, such as daily weather variables, to
make the MAR assumption more plausible. Further, MI
also allows for the relatively simple implementation of
sensitivity analysis to assess the robustness of the results
to the untestable missing data assumptions [16]; see Har-
ris et. al. (2017) for an example of a sensitivity analysis on
the possible impact of step counts being MNAR [5].
In this paper, we propose a framework for handling
missingness in accelerometer outcome data. This involves
aggregating step counts on the day level, and classify-
ing them into missing, partially observed, and observed
step counts, and identifying appropriate assumptions
for the missing and partially observed data. Then, MI
can be used to impute daily step counts; the imputed
datasets can be analysed to take into account the uncer-
tainty due to the missing data. We implement this
framework in an analysis of the MOVE-IT trial. In
the “Motivating Example: MOVE-IT trial” section, we
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introduce the MOVE-IT trial, and we describe the pri-
mary analysis typically conducted in accelerometer trials
in “Primary analysis.” In the “What constitutes a missing
step count?” section, we explore the definition of miss-
ing data in the accelerometer setting. We then elucidate
our framework for MI in the “Framework for handling
missing data” section, where we set out our recommen-
dations for classifying daily step counts into observed,
partially observed and missing data, where assumptions
need to be specified for the missing and partially missing
data. We outline the need to include auxiliary variables
to strengthen the MAR assumption, and we outline how
MI can be conducted with Tobit regression to account for
partially observed data. In the “Applying the framework
to the MOVE-IT trial” section, we illustrate the approach
with data from the MOVE-IT trial and display the results.
Finally, there is a “Discussion” section.
Motivating Example: MOVE-IT trial
Throughout this paper, we use data from the MOVE-IT
trial to demonstrate the decisions needed in conducting
an analysis of accelerometer data with MI, and associated
analysis results. The trial investigated the effects of moti-
vational interviewing and motivational group therapy for
patients at high risk of cardiovascular disease (QRISK2
of 20% or higher [17]) in reducing weight and increasing
physical activity. The trial randomized patients to one
of the following: individual motivational interviewing,
motivational group therapy, or usual care. Individual
motivational interviewing and motivational group ther-
apy consisted of ten sessions over the course of a year.
Between June 2013 and February 2015, 1742 participants
were recruited from 135 general practices across the
12 South London Clinical Commissioning Groups. We
focus on step count as a measure of physical activity. The
participants were provided with an ActiGraph GT3X
accelerometer (ActiGraph, FL, USA) for a period of seven
consecutive days on three occasions: baseline, 12 months,
and 24 months. The protocol and results of the trial have
been reported previously [3, 18, 19]. There was insuffi-
cient evidence from the trial to recommend motivational
interviewing or motivational group therapy for reducing
weight or increasing physical activity.
Primary analysis
We assume that, in common with many clinical trials,
the primary analysis investigates whether the interven-
tion led to any change in step count as a measure of
physical activity between baseline and post-intervention
measurements. The outcome is step count averaged over
the measurement period, and if there is more than
one post-intervention measurement, a multilevel analy-
sis is typically needed to account for the clustering of
observations per participant ID. An advantage of using
averaged step count as the outcome is that a model on the
untransformed scale is likely to fit reasonably well. Daily
step counts are generally more left-skewed than averaged
step counts. For example, in theMOVE-IT trial data, Fig. 1
shows histograms of step counts for a randomly chosen
day within each measurement period: Monday for base-
line, Sunday for year 1 and Wednesday for year 2 on the
left, and the log of those counts on the right. If step counts
are analysed at the daily level, then a log transformation
is likely to be needed if the analysis relies on multivariate
normality, which will in turn have implications both for
the interpretation of the analysis and for the imputation
model.
We assume that the average step count across the mea-
surement period is our outcome. To illustrate a possible
primary analysis using the MOVE-IT trial as an exam-
ple, suppose that yi,j,k is the step count for patient i at
year j on day k, where i ∈ {1, ..., 1742}, j ∈ {0, 1, 2} and
k = {1, 2, ..., 7}. We define ȳi,j,. as the average step count





and we denote by armi the arm that participant i was
assigned to, which takes values 1, 2 or 3, correspond-
ing to individual therapy, group therapy and usual care,
respectively. In theMOVE-IT trial, in the absence of miss-
ing data, the pre-specified primary analysis model has
a baseline-year interaction, a treatment-year interaction,
and fixed effects for sex, age and borough, so can be
written, for j ∈ {1, 2}:
ȳi,j,. = β0 + β1year 2i,j + β2I(armi = 1) + β3I(armi = 2)
+ β4year 2i,j × I(armi = 1) + β5year2i,j
× I(armi = 2)
+ β6ȳi,0,. + β7year 2i,j × ȳi,0,. + β8femalei + β9agei
+ β10b1i + β11b2i + ... + β21b11i + ei,j,
(2)
where covariates in the model include:
• year 2, the dummy variable for whether the
observation is from year 2;
• female, the dummy variable for whether the
participant is female;
• age, the age of the participant at baseline in years
(centred);
• b1, b2, ..., b10, b11, dummy variables for the borough
of London that the participant resides in.
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Fig. 1 Histograms of step counts for Monday at baseline, Sunday at year 1 and Wednesday at year 2 (left) and histograms of the logged step counts
(right)
To take account of the effect of the intervention on the
variance, the primary analysis also specifies an unstruc-
tured correlation matrix for the residuals by arm:
(
ei,1, ei,2
) ∼ N (0,armi
)
, (3)









where σ 2j,armi denotes the variance of residuals for year j for
patients assigned to armi, and σ12,armi = σ21,armi denotes
the covariance between residuals at year 1 and year 2 for
patients assigned to armi.
In this trial design, patient outcomes in the group ther-
apy arm may also be correlated because of a common
therapy group effect. We investigated including a random
effect to model this, but there appeared to be insuffi-
cient information in the data to support this, causing
the model not to converge. Working with this primary
analysis model, our goal is to handle the missing data
appropriately. This requires, first, a discussion of what
constitutes missing data in the accelerometer setting.
What constitutes amissing step count?
Accelerometers measure acceleration in three dimensions
at the epoch level, which is typically set to 5- or 10-s inter-
vals. These are then converted to step counts over the
epoch. There are two main issues associated with defining
missing accelerometer data. Firstly, it is difficult to dis-
tinguish between periods where participants are wearing
the device as per protocol but are inactive, and periods
where data is missing as the participant has stopped wear-
ing the device. In both instances, the accelerometer will
register zero step counts over the epochs of that time
period. Secondly, step counts at the epoch level are gen-
erally aggregated at a higher level, usually at the day level.
Missingness then needs to be defined at this higher level.
Measuring the wear time of the accelerometer is impor-
tant in addressing both of these issues. Wear time is the
length of time that the device is worn per day. To address
the first issue, the accelerometer is typically set to ignore
long runs of epochs with zero step counts, where a long
run is often defined to be a period that is longer than 20,
40 or 60 min [20]. Thus, during long periods where no
acceleration is detected by the device, it is assumed that
the participant has stopped wearing the device and the
epochs within such periods are instances of missing data.
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More sophisticated methods of defining wear time are
continually being developed; see, for example, Syed et al.
(2020) [21].
To address the second issue, most authors impose a cut-
off at the day level for the number of steps taken or wear
time, where days that do not achieve the cut-off are viewed
as a missing observation, and any step counts collected
that day are discarded. For example, De Craemer et al.
(2016) require a minimum of 6 h of wear time [22], while
some other authors require more than 10 h of wear time
per day [9, 23]. Some authors impose an additional cut-
off on the number of missing days in the measurement
period, and the entire period is regarded as missing if this
condition is not met. For example, Bade et al. (2018) con-
sider data from a participant to be missing if less than 200
steps were taken per day or if data for less than 5 days
were collected per week [10]. Kloeck et al. (2018) state that
data from a participant across the measurement period is
valid if patients wore the device for ≥ 3 days, for ≥ 8 h
per day [12]. Kipping et al. (2014) require that participants
have 3 days (out of five) with at least 8 h of wear to be
considered valid [11].
Our recommendation is to aggregate data on the day
level, which appears natural as participants are typically
provided with instructions on how to wear the device over
the course of a day (for example, to wear between wak-
ing and sleeping, except when bathing or swimming). We
then recommend imposing a cut-off in terms of wear time
to distinguish between observed step counts and partially
observed step counts. Thus we define a daily step count
value as observed, yobsi,j,k , when wear time is greater than
the cut-off value. A step count value is partially observed,
ypartiali,j,k , if wear time is between zero and the cut-off (exclu-
sive). A missing step count, ymisi,j,k , occurs when the device
is not worn and the wear time is zero. Where participants
wear the device but provide an insufficient amount of time
for a particular day, the step counts of that day are treated
as right-censored data, rather than discarding this infor-
mation as missing. The cut-off value should be explicated
in the trial protocol. While total step counts are often of
interest in exercise trials, we note that this framework is
applicable more generally. For example, if there is interest
in the number of steps taken over a specific part of the day,
it is equally possible to define observed, partially observed
and missing step counts in an analogous way.
Though participants are typically required to provide
step counts for consecutive days over a measurement
period, sometimes, participants may provide data for days
before or after the measurement period if they wore the
accelerometer for longer than necessary. If we can assume
that step counts of a particular participant are exchange-
able across adjacent weeks, given the day of the week,
we can substitute missing daily step count ymisi,j,k with an
observed step count yobsi,j,k from day k of the following week,
or it can be substituted with a partially observed step
count ypartiali,j,k from the following week if no observed step
count is available. Further, a partially observed step count
ypartiali,j,k from the measurement period can be substituted
with an observed step count for day k from the follow-
ing week. For example, if a participant’s step count for
Tuesday is missing during the 7-day measurement period,
but there is either an observed or partially observed step
count for the following Tuesday, the observed or partially
observed step count would be used in the analysis. We
refer to this as day-substitution. Where the assumption of
exchangeability across weeks, given the day of the week, is
plausible, day-substitution allows for a greater amount of
information from the data collection to be retained for the
analysis. Day-substitution would not be appropriate if, for
example, participants chose not to wear the accelerome-
ter during the first week because they were less active and
tried to compensate by being more active the following
week. It is thus crucial to consider whether the distribu-
tion from which the later step count is drawn is the same
as that from which the missing step count is drawn. Ide-
ally, day-substitution should be an a priori decision built
into the protocol where participants are instructed not
to wear the accelerometer for more than seven full days;
where there are days with insufficient wear, the participant
is asked to wear the accelerometer in the following week,
on the same day of the week.
In the MOVE-IT trial, participants were told to wear
the accelerometer all day between waking up and sleep-
ing, removing the device only when bathing or swim-
ming. Runs of zero counts lasting 60 min or longer were
ignored when calculating wear time. Daily step counts
were deemed observed when wear time is greater than
540 min, which was specified in the protocol. According
to the protocol, if participants failed to wear the device
for at least 540 min on each of at least 5 days at baseline,
they were asked to wear the accelerometer for another
7 days [19]. This was also done in the PACE-LIFT trial
[4]. This particular practice reduces missingness at base-
line. However, only 2.35% of patients provided data with
wear time of greater than 540 min for seven consecu-
tive days at baseline, year 1 and year 2, demonstrating the
ubiquity of missing data. A further complication is that,
several participants wore the accelerometer for more than
7 days. Figure 2 displays the number of observed, partially
observed and missing observations for each combination
of day of the week, arm and year when day-substitution is
carried out in the top row, and when it is not carried out
in the bottom row.We observe that day-substitution leads
to slightly fewer missing and partially observed values.We
note that there is a greater number of observations in the
group therapy arm as the recruitment ratio was 3 : 4 : 3
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Fig. 2 Frequency of daily step count observations for each day of the week at baseline (left), year 1 (center) and year 2 (right) classified as observed
(green), partially observed (yellow), and missing (red) when day-substitution is used (top row) and when day-substitution is not used (bottom row)
for the individual therapy, group therapy and usual care
arms, respectively.
In the MOVE-IT trial, using day-substitution affects
not only the proportion of missing and partially observed
step counts, but it also affects the distribution of step
counts. Figure 3 displays boxplots showing the distri-
bution of logged step counts for complete observations
(wear time ≥ 540), and that of partial observations (0 <
wear time < 540) in the bottom row for each year when
day-substitution is carried out (in red) and when it is
not carried out (in green). For observed step counts, we
see that day-substitution makes very little change to the
distributions. For the partially observed step counts, we
observe that the median of the boxplots are higher when
day-substitution is carried out. For partially observed
step counts, it appears that day-substitution leads to a
higher number of steps. This is due to the fact that par-
ticipants have increased wear time on substitute days;
a visualization of the distribution of wear time in the
“Wear time” section displays a similar pattern to Fig. 3.
This suggests that the exchangeability assumption across
weeks given the day of the week may not be plausible in
this setting. Day-substitution based on a criterion other
than day of the week may be more appropriate. For exam-
ple, in the “Auxiliary variables” section, we show that the
level of sunshine during the day is predictive of miss-
ingness and also of step count. A missing step count in
the measurement period could be substituted with a step
count from a day outside of the measurement period with
a similar level of sunshine.
Framework for handlingmissing data
Analysis of data with missing values requires assumptions
about the missingness mechanism. A popular categoriza-
tion of these mechanisms was provided by Rubin (1976)
[15]. Under the assumption that the data are missing
completely at random (MCAR), the probability that an
observation is missing is independent of the observed or
unobserved data. The assumption that the data are miss-
ing at random (MAR) states that the probability that an
observation is missing is independent of the unobserved
data, conditional on the observed data. In our setting, this
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Fig. 3 Boxplots showing the distribution of the log of observed daily step counts (top) and log of partially observed step counts (bottom) at
baseline, year 1 and year 2 when day-substitution is carried out across weeks (red) and when it is not carried out (green)
means that, within groups of step count outcomes defined
by the observed covariates, the probability of an observa-
tion beingmissing is the same. Finally, the assumption that
the data are missing not at random (MNAR) states that
the probability that an observation is missing depends on
the unobserved data. Inference under MNAR requires a
specification of how the conditional distributions of the
step counts given the observed covariates differ for those
participants who do, and those do not, have missing out-
comes [24, p. 17]. It is not possible to prove that the MAR
assumption is met using only the observed data, so sensi-
tivity analyses are needed to understand the robustness of
the results to the MAR assumption [25].
In this framework for handling missing step counts,
we define missing data on the epoch level as a long
run of zeros, typically set to 60 min. We then aggre-
gate the step counts at the day level, as there are sev-
eral advantages for doing so. Firstly, as mentioned in the
“What constitutes a missing step count?” section, it may
be possible in some cases to substitute missing or par-
tially observed step counts with step counts from outside
the measurement period on the same day of the week.
This allows for a greater proportion of collected data to
be retained for the analysis. Secondly, partially observed
daily step counts can be incorporated in the imputation
model. Partially observed data can be regarded as right-
censored data, as the true step count is higher than that
observed if the participant prematurely stopped wearing
the accelerometer; this can be incorporated in the impu-
tation model though Tobit regression. Thirdly, while step
counts averaged across the measurement period are likely
to be MNAR, since participants may be more vigilant
about wearing the accelerometer during periods when
they are active, and may remove the device during seden-
tary periods, the assumption can be made more plausible
for daily step counts by the inclusion of auxiliary variables
such as day of the week or weather variables. The four key
decisions in our framework for obtaining an appropriate
imputation model for daily step count data are as follows:
1 Whether to use day-substitution. The assumption of
exchangeability of step counts across weeks can be
assessed by inspecting the distributions of the
observed and partially observed step counts when
day-substitution is used, and when it is not, as shown
in Fig. 3. If there is evidence that participants who
wear the accelerometer outside of the measurement
period are doing so because they are more physically
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active outside of the measurement period, this
assumption would incur bias.
2 Whether to impute ypartiali,j,k as censored data or to
impute them as missing data. If they are imputed as
censored data, this means that ypartiali,j,k is the lower
bound for the number of steps that the participant
took that day; incorporating this leads to a slightly
more complicated analysis, which can be achieved
using MI. It may be that, for some days, participants
fall short of the threshold for a complete observation
by a small margin; in this case, partially observed data
provide a lot of information about the participants’
activity so there is a strong case for incorporating
partially observed data.
3 Whether to assume MAR for ymisi,j,k and/or y
partial
i,j,k .
Under the MAR assumption, the expected number of
steps that participants take when they wear the
accelerometer is the same as the expected number of
steps that they take when they forgo wearing the
accelerometer, conditional on all other variables. If
participants are more likely to wear it on active days
compared to inactive days, these assumptions would
be inappropriate. Using sensitivity analysis via MI, it
is possible to explore scenarios where step counts are
missing not at random, for example, where
participants’ propensity to exercise is reduced in the
periods where they are not wearing the
accelerometer.
4 Whether to use auxiliary variables. If the MAR
assumption is made above, the addition of auxiliary
variables may strengthen its plausibility. This is
discussed in more detail in the “Auxiliary variables”
section.
Five possible approaches to the decisions outlined above
are given in Table 1, which correspond to the primary
analysis, the key sensitivity analysis, and three possible
additional sensitivity analyses:
• Plausible: This is our recommended model for the
primary analysis. Day-substitution is not carried out,
and ypartiali,j,k are imputed as censored. We assume that
ymisi,j,k and y
partial
i,j,k are MAR given variables in the
imputation/analysis model, and auxiliary variables are
included in the imputation model.
• Suspicious: This is our recommended model for the
sensitivity analysis. As in the Plausible model,
day-substitution is not carried out, and ypartiali,j,k are
imputed as censored. However, we explore in this
analysis the sensitivity to departures from the MAR
assumption. Under this model, we assume that the
step counts are likely to be lower if participants have
removed their accelerometer by a proportion δ.
Auxiliary variables are included.
• Plausible-no-aux: The Plausible model with auxiliary
variables omitted.
• Replace-days: Day-substitution is carried out
assuming that participants’ step counts are
exchangeable across weeks, given the day of the week.
Then, ypartiali,j,k are imputed as censored and y
mis
i,j,k and
ypartiali,j,k are assumed to be MAR given the variables in
the imputation/analysis model. Auxiliary variables
are included in the imputation model.
• Dismissive: Day-substitution is not carried out.
Further, if we have partially observed data ypartiali,j,k ,
they are discarded and treated as ymisi,j,k . We assume
that ymisi,j,k are MNAR. We assume that the log of step
counts are lower by a proportion δ if participants
removed their accelerometer for the entire day.
Auxiliary variables are included.
Auxiliary variables
An advantage of using MI is that it is possible
to incorporate auxiliary variables into the imputation
model which makes the MAR assumption more plau-
sible. Auxiliary variables are variables which are pre-
dictive of missingness of the outcome and also of
the value of the outcome [24, p. 64]. They are not
conditioned on in the primary analysis; the advan-
tage of using MI is the separation of the imputation
and analysis models which allows for an imputation
model where the MAR assumption can be made more
plausible.
Table 1 Framework for assumptions on missing data
Primary Key sensitivity Other sensitivity nalyses:
analysis: analysis:
Decisions Plausible Suspicious Plausible-no-aux Replace-days Dismissive
Use day-substitution? ✗ ✗ ✗  ✗
Impute as censored?     ✗
AssumeMAR?  ✗   ✗
Use auxiliary variables?   ✗  
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For example, in the MOVE-IT trial, Body Mass Index
(BMI) at baseline was found to be predictive of both
average step count and missingness at the week level
at the 5% level of significance. Further, we consid-
ered weather variables as potential auxiliary variables.
A number of longitudinal studies have demonstrated a
link between weather and physical activity; activity has
been shown to decrease with increased rainfall [26–28].
When temperature diverges from the average climate tem-
perature, physical activity has been shown to decrease
[26, 28, 29] and increased daylight hours has been shown
to be associated with increased physical activity [30]. In
the MOVE-IT trial, the following weather variables were
individually found to be predictive of both daily step count
values and missingness at the 5% level: maximum air
temperature during the day between 9AM and 9PM (tem-
perature), the square root of the total rainfall per day for
the 24-h period inmillimetres (rainfall), sunshine duration
in hours (sunshine) and daylength in hours (daylength).
We therefore include BMI at baseline and these weather
variables as auxiliary variables in our analysis. In the
“Obtaining weather data” section, we describe how we
obtained the weather data. The MAR assumption may be
more plausible after accounting for the participants’ BMI
at baseline and day-level weather variables, in addition to
variables included in the primary analysis.
Imputation
After defining a model for the primary analysis such
as in Equation 2, defining missingness in the context
of accelerometer data and constructing a set of possi-
ble assumptions for the missing data such as in Table 1,
the next step is to identify an approach for imputing
the missing data under those assumptions. Some analy-
ses of accelerometer data with missing observations have
involved imputation using the Expectation-Maximization
(EM) algorithm. Catellier et al. (2005) showed in a sim-
ulation that single imputation using the EM algorithm
and multiple imputation had similar performance in term
of bias and precision [7]. In general, we do not recom-
mend this approach as single imputation does not take
full account of the uncertainty. We recommend the use of
multiple imputation (MI) to handle missing data in this
context as it allows for:
1 The separation of the imputation and analysis
models so that the imputation model can have step
counts on the day level and the analysis model can
have step counts on the week level;
2 The incorporation of partially observed (bounded
below) step count data with Tobit imputation;
3 The addition of auxiliary variables;
4 The relatively simple use of sensitivity analysis to
explore a range of missingness assumptions.
Tobit regression
For our models which incorporate partially observed
daily step counts, Tobit imputation can be used. Tobit
regression is a method for estimating linear relation-
ships between variables when the outcome is left- or
right-censored [31, 32]; in our setting, the accelerometer
outcome is right-censored for participants who wear the
device for an insufficient amount of time. Tobit regression
can be implemented using interval regression in
STATA, which requires specification of lower and/or
upper bounds for each observation. For completely miss-
ing daily step counts, the lower bound is zero, and for
partially observed daily step counts, the lower bound is
the recorded step count. The upper bound can be set to
a limit chosen to be greater than any observed daily step
count. For complete observations, the lower and upper
bound are the recorded value. Thus the imputation model
is specified such that draws from the posterior predictive
distribution of the missing values given the observed data
are bounded between the recorded value and the cho-
sen upper limit for partially observed step counts, and
bounded between zero and the chosen upper limit for
missing step counts.
Software
Currently, the only available Tobit imputation routine
which combines the resulting imputed datasets for a
mixed model primary analysis with a complex resid-
ual structure is in STATA with chained equations: mi
impute chained (intreg). It was originally writ-
ten for the ice macro [33]. We provide example code in
Additional file 1.
A recent R package hmi [34] is able to handle mul-
tiple imputation for interval data and can be used if
the primary analysis is a linear regression or a multi-
level model with homoscedastic residuals. As it currently
only allows for homoscedastic residuals, it would not be
appropriate in the analysis of the MOVE-IT trial where
the primary analysis has a complex residual structure.
The extension of other R packages for multiple imputa-
tion, such as jomo [35], to incorporate routines for the
interval regression setting is a possible avenue for further
exploration.
Applying the framework to theMOVE-IT trial
We now describe how the imputation model is specified
for the MOVE-IT trial for the five possible assumptions
in Table 1. Our imputation model has the log of the step
count as the outcome; this allows us to impute missing
step counts conditional on other days of the week that
year, as well as days from the other 2 years, and important
auxiliary variables. After imputation, theM sets of logged
step counts are then exponentiated to obtain daily step
counts, and averaged across the 7-day measurement
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period in order to obtain week-average step counts for
the analysis model.
The Replace-days and Plausible assumptions for the
missing data incorporate partially observed data log ypartiali,j,k
into the analysis, so we use Tobit regression. We set the
lower bound li,j,k as log y
partial
i,j,k and we set the upper bound
ui,j,k at a value that is at least as high as the log of the
highest step count observed in the study. We note that
the Suspicious and Dismissive assumptions for the miss-
ing data, which do not incorporate partially observed data,
could be handled using linear regression instead of Tobit
regression. However, using linear regression can lead to
imputed values which are much higher than the upper
bound ui,j,k , which in turn leads to an unrealistically high
step count when exponentiated. To keep the results under
the five sets of assumptions for the missing data compara-
ble, we use Tobit regression for all four imputation models
where the upper bound for missing or partially observed
log counts are set to ui,j,k .
We explore the possibility that the step counts are
missing not at random in the Suspicious and Dismis-
sive assumptions for the missing data, where we assume
that participants’ propensity to exercise is reduced in the
periods where they are not wearing the accelerometer.
We assume that, under MNAR, log ypartiali,j,k is 0.95 times
that obtained under the MAR assumption. Similarly for
missing data, under MNAR, we assume that log ymissingi,j,k
is 0.95 times that obtained under the MAR assumption.
This means that, after MI under the MAR assumption,
we simply multiply the resulting log step counts which
were missing or partially missing in the study by 0.95. The
assumption that step counts are 5% less than that expected
under MAR on the log scale implies that, on the step
count scale, a greater expected step count under MAR
means that a greater reduction of steps is needed to obtain
the expected step count under MNAR. An expected step
count of 30000 under MAR is exp(log(30, 000) × 0.95) =
17917 under MNAR, and an expected step count of 500
under MAR is exp(log(500) × 0.95) = 366.45 under
MNAR.
We impute separately for each arm. We denote by
log yli,j,k the log of the step count for participant i in year j
on day k with the superscript l = armi. Further, we denote
by log(yli,j,.) the average of the seven logged step counts for






log yli,j,k . (5)
The baseline log step counts log yli,0,q are imputed con-
ditional on the baseline log step counts from other days
of the week, the log step counts from year 1 and log step
counts from year 2, as well as the variables of interest in
the analysis model and the additional auxiliary variables.
The mean of the baseline log step counts is updated as
a result of this imputation. Then, the log step counts for
year 1, log(yli,1,k) are imputed conditional on the mean
of the baseline log step counts, the log the year 1 step
counts from other days of the week, and the log of the
year 2 step counts. The year 1 daily log step count is
updated. Finally, the log step counts for year 2, log(yli,2,k)
are imputed conditional on the mean of the baseline log
step count, the log of the year 1 step counts, and the log
of the year 2 step counts from the other days of the week.
The year 2 daily log step count is then updated. This is
then repeated ten times. We note that, in the imputation
of year 1 and year 2 log step counts, instead of including
daily logged step counts at baseline, we include their aver-
age log(yli,0,.) to reduce noise that may be introduced in
the model.
For arm l, l ∈ {1, 2, 3} to impute the baseline logged



























+ κ1femalei + κ2agei + κ3b1i + κ4b2i + ...
+ κ14b11i
+ κ15BMIi + κ16tempi0q + κ17precipi0q
+ κ18suni0q
+ κ19daylengthi0q + ei,0.
(6)
To impute the logged step count in year 1 for patient i























+ κ1femalei + κ2agei + κ3b1i + κ4b2i
+ ... + κ14b11i
+ κ15BMIi + κ16tempi1q + κ17precipi1q
+ κ18suni1q
+ κ19daylengthi1q + ei,1.
(7)
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To impute the logged step count in year 2 for patient i























+ κ1femalei + κ2agei + κ3b1i + κ4b2i
+ ... + κ14b11i
+ κ15BMIi + κ16tempi2q + κ17precipi2q
+ κ18suni2q
+ κ19daylengthi2q + ei,2,
(8)
and we assume that the residuals are normally dis-




for l ∈ {1, 2, 3} and
j ∈ {0, 1, 2}.
We set the number of imputationsM to 20 and the num-
ber of cycles (burn-in) to 10. After the daily logged step
counts are imputed, they are exponentiated and averaged
across each week, so that we have 20 complete data sets.
The analysis model from Eq. 2 is fitted to each of the 20
complete data sets and then combined using Rubin’s rules.
Results for the MOVE-IT trial
We considered five possible sets of assumptions for the
missing data: the Plausible approach which is our pre-
ferred model for the primary analysis, the Suspicious
model which is the key sensitivity analysis, and three fur-
ther sensitivity analyses: the Plausiblemodel without aux-
iliary variables; the Replace-days approach which retains
the most amount of data, but involves the use of day-
substitution which may not be appropriate in this setting;
and finally, the Dismissive model which does not impute
partially observed data as censored data and assumes
that the step counts are MNAR. In Fig. 4, we display
the 95% confidence intervals for the difference in average
step count for each intervention compared to usual care
(arm 3) for year 1 and year 2. Overall, neither the moti-
vational interviewing or group therapy are shown to be
effective under the five possible missing data assumptions.
However, we note that the there are noticeable differ-
ences in the point estimates and variances of the contrasts
which reveal the potentially large impact that missing
data assumptions can have on the results of the primary
analysis.
We observe that the point estimate of the contrast is
higher for year 1 than year 2 within each model, and the
point estimate is higher for arm 1 than arm 2 within each
model. We first examine how the missing data approaches
impact the point estimates of the contrasts. The Replace-
days assumption leads to estimates of the contrast that are
higher than the other assumptions for year 1. However,
this increase may be because the assumption of exchange-
ability of step counts across weeks, given the day of the
week, may not be appropriate as it appears that partici-
pants’ wear times are higher outside of the measurement
period for partially observed days, as shown in Fig. 5. The
point estimates using the Plausible assumption appear to
change only slightly when auxiliary variables are omitted
in the imputation model. We observe that, as expected,
the models that assume MAR (Replace-days, Plausible,
Plausible-no-aux) lead to higher estimates of the contrasts
compared to the models that assume MNAR (Suspicious
and Dismissive).
Next, we examine how the missing data approaches
impact the variances of the estimates of the contrasts.
Replace-days leads to the most precise estimates of the
contrast; this is due to the fact that day-substitution has
been carried out which leads to a smaller proportion of
missing and partially missing observations, as shown in
Fig. 2. Comparing the Plausiblemodel with the Plausible-
no-aux model, we observe that the addition of auxiliary
variables generally leads to wider confidence intervals.
Omitting these auxiliary variables may lead to an under-
estimate of the variation due to, for example, variation
related to weather. In general, we recommend the addi-
tion of auxiliary variables to the imputation model as they
lead to increased plausibility of theMAR assumption. The
models that assume MAR lead to higher variances in the
estimates of the contrasts compared to the models that
assume MNAR.
In Table 2, we display the estimates of the fixed effects
for the primary analysis under the five different models
for the missing data. Across the five models, the follow-
ing variables are significant predictors of step count in
year 1 and year 2: sex; age; average step count at base-
line and the interaction between average step count at
baseline and year. Taking the Plausiblemodel as an exam-
ple, the expected step count is 421.4 steps lower for
females than males, holding all other variables constant.
The expected step count drops by 40.84 steps per year
increase in age, holding all other variables constant, for
this older group of participants where the mean age of
the participants is 69.75 years [3]. A one-unit increase
in baseline step count leads to an increase of 0.782 for
steps in year 1, and 0.731 steps in year 2, holding all vari-
ables other than year and baseline step count constant.
For the Suspicious and Dismissive models which assume
MNAR, the effect of arm 1 is lower than for the other three
models.
The estimates of the random effects, and further
details of the results of this analysis, are shown in the
“MOVE-IT trial analysis: further results” section.
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Fig. 4 Forest plot showing estimates for the difference in average step count per week for arms 1 and 2 compared to arm 3 for year 1 and 2 for
several different choices of models
Discussion
In this paper, we set out to address a need to create
guidelines for analysing accelerometer outcome data with
missing values from clinical trials. There are several chal-
lenges to consider: firstly, the primary analysis typically
has as the outcome the average number of steps over a
measurement period, and these averaged step counts are
likely to be MNAR, given the observed variables in the
primary analysis. Secondly, missingness for step counts
is typically defined on the day level, which is a different
measurement level to what we use in the primary anal-
ysis. Thirdly, some step count observations are partially
observed, so there is a need to incorporate bounded below
observations in the analysis.
We propose a framework for identifying the key deci-
sions and assumptions needed for handling missing daily
step counts. Multiple Imputation can then be used to
impute day-level step counts. MI allows for the separa-
tion of the imputation and analysis models, so we can
have an imputation model for daily step counts and a
primary analysis model for averaged step counts over
the measurement period. The imputation model is flexi-
ble and can allow for Tobit regression, so that censored
(bounded below) observations can be incorporated, and
further, auxiliary variables on the day level, such as day
of the week and weather, can be included to strengthen
the assumption that day-level step counts are MAR given
the variables in the imputation model. MI also allows for
the relatively simple use of sensitivity analysis to explore a
range of missingness assumptions.
Our framework elucidates a number of key questions
that need to be answered in order to obtain an appropriate
imputationmodel. Such questions include: shouldmissing
step counts be replaced with step counts from outside of
the measurement period? Should partially observed step
counts be treated as censored data, or treated as com-
pletely missing data? Are missing and partially missing
data MAR, given the variables in the imputation model?
We illustrate sets of possible answers to these questions
which constitute an approach for the primary analysis,
as well as possible ways to conduct sensitivity analyses.
While we focused on primary analysis models where the
average step count over the measurement period is the
response, our framework is also applicable to analysis
models for baseline adjusted daily step counts.
There are a number ways in which this work could
be extended. Firstly, we note that step count is only one
of several accelerometer outcomes. Modern accelerome-
ters also typically measure time spent in the three types
of activity levels: moderate-to-vigorous physical activ-
ity (MVPA), light physical activity (LPA) and seden-
tary behaviour (SB). Time spent in MPVA is a com-
mon accelerometer outcome in exercise studies. Many
aspects of our framework, such as defining observed, par-
tially observed and missing days using wear time, and
the potential use of day-substitution and auxiliary vari-
ables, would readily apply to the time spent in MVPA
outcome. The imputation approach for right-censored
observations would need to be adapted so that the upper
bound is defined appropriately for time spent in MVPA.
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Secondly, the extraction of epoch-level data could lead to
a more detailed exploration of the missing data mecha-
nism. Epoch-level data can be used to investigate the times
of day when participants are active, which could provide
further insight into whether the MAR assumption is plau-
sible for partially observed days. Taking this approach,
the cut-off to distinguish between observed and partially
observed days could be whether wear time between, say,
9AM and 6PM, is at least 540 min, rather than whether
wear time over the entire day is at least 540 min. This
would remove a slight ambiguity in the current approach.
Thirdly, our exploration is specific to step count data.
Rapid developments in technology have allowed wearable
devices to measure a plethora of health-related quantities
such as gait, body temperature, and blood oxygen satura-
tion [36]. Mobile phones are increasingly being used for
behaviour change interventions; see, for example, a review
by Oikonomidi et al. (2019) [37]. The problem of missing
data will pertain to this vast range of outcomes in wear-
ables. There is thus a need to expand our framework to
allow for a range of data types in the outcome, as well as a
range of analysis approaches.
We have developed a framework for analysing data from
trials with accelerometer outcome measures, and illus-
trated this with the MOVE-IT trial. Our results show
that the point estimates and variances for the contrasts
are considerably affected by the missing data assump-
tions and the presence of auxiliary variables in the impu-
tation model. While, in this particular trial, the over-
all conclusion of the effectiveness of the intervention
remains unchanged, more generally a careful elucida-
tion of the missing data through our framework may
lead to different conclusions. We therefore advocate the




To investigate whether the distribution of wear time is
affected by day-substitution, we display boxplots show-
ing the distribution of wear time for complete observa-
tions in the top row and wear time for partial obser-
vations (bottom row) for each year when the day-
substitution is carried out (in red) and when it is not
carried out (in green) in Fig. 5. For complete observa-
tions, the distribution of wear time appears unaffected
by day-substitution; the median wear time is approxi-
mately 750 min or 12.5 h. For partially observed step
Fig. 5 Boxplots showing the distribution of wear time for observed step counts (top) and wear time for partially observed step counts (bottom) at
baseline, year 1 and year 2 when day-substitution is carried out across weeks (red) and when it is not carried out (green)
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Table 2 Fixed effects of the analysis models where the imputation has been conducted under the Replace-days, Plausible, Suspicious
and Dismissive assumptions for the missing data





arm1 211.4 (1.60) 131.9 (0.81) 122.3 (0.80) 54.44 (0.39) 66.44 (0.51)
arm2 87.91 (0.72) 19.26 (0.13) 42.49 (0.27) − 42.30 (− 0.33) − 31.46 (− 0.25)
year2 201.3 (1.26) 10.43 (0.05) 27.90 (0.14) 146.0 (0.90) 87.21 (0.61)
arm1 year2 − 162.5 (− 1.11) − 16.08 (− 0.10) − 65.06 (− 0.41) − 141.0 (− 1.00) − 178.9 (− 1.38)
arm2 year2 − 167.6 (− 1.32) − 109.6 (− 0.78) − 145.6 (− 1.01) − 143.9 (− 1.15) − 148.5 (− 1.28)
ȳi,0,. 0.804*** (40.75) 0.782*** (28.83) 0.781*** (35.09) 0.729*** (35.28) 0.728*** (35.20)
year2 ȳi,0,. − 0.0597*** (− 3.08) − 0.0509* (− 1.86) − 0.0518* (− 1.97) − 0.0560** (− 2.58) − 0.0449** (− 2.26)
female − 424.1*** (− 3.13) − 421.4*** (− 2.85) − 395.5*** (− 2.63) − 432.0*** (− 3.23) − 403.0*** (− 3.12)
age − 31.87*** (− 2.70) − 40.84*** (− 3.23) − 43.11*** (− 3.45) − 28.73** (− 2.46) − 28.84** (− 2.47)
b2 104.4 (0.49) 44.31 (0.19) 102.9 (0.44) 336.7* (1.67) 331.6 (1.63)
b3 − 30.92 (− 0.12) − 235.1 (− 0.88) − 241.9 (− 0.92) 29.22 (0.13) 34.00 (0.15)
b4 276.1 (0.92) 176.9 (0.59) 204.2 (0.58) 315.8 (1.02) 288.4 (1.03)
b5 − 72.39 (− 0.33) − 205.3 (− 0.79) − 190.0 (− 0.83) 11.70 (0.05) 50.39 (0.23)
b6 179.9 (0.53) 57.69 (0.16) 110.0 (0.31) 215.6 (0.68) 153.5 (0.48)
b7 51.05 (0.22) 3.919 (0.01) 12.77 (0.05) 215.1 (0.98) 212.5 (0.93)
b8 300.2 (0.84) 374.6 (1.06) 387.8 (1.06) 684.1** (2.24) 686.4** (2.21)
b9 534.8 (1.60) 430.8 (1.32) 396.5 (1.09) 463.0 (1.55) 489.6 (1.57)
b10 − 55.07 (− 0.20) − 120.4 (− 0.44) 0.233 (0.00) 267.6 (1.01) 251.4 (0.97)
b11 93.24 (0.34) − 142.0 (− 0.46) − 177.4 (− 0.61) 121.0 (0.46) 156.0 (0.60)
intercept 1239.9*** (5.10) 1592.1*** (5.28) 1561.6*** (5.76) 1261.7*** (5.12) 1237.2*** (5.36)
N 3462 3462 3484 3462 3462
All imputations include auxiliary variables, except for the Plausible model with no auxiliary variables. Values of t-statistics are given in parentheses
Table 3 Random effects of the analysis models where the imputation has been conducted under the Replace-days, Plausible,
Suspicious and Dismissive assumptions for the missing data
Replace-days Plausible Plausible-no-aux Suspicious Dismissive






























































































All imputations include auxiliary variables, except for the Plausiblemodel with no auxiliary variables
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Fig. 6 For the Plausiblemodel: distribution of the imputed logged step counts for each combination of day of the week, year and arm. Imputed
logged step counts forM = 1 are shown
counts, however, it appears that the average wear time
is longer when day-substitution is carried out, suggest-
ing that the exchangeability assumption across weeks




We used daily temperature data from the Met Office [38].
We used data from the Heathrow weather station and
obtained the maximum and minimum air temperature
during the day (9:00–21:00).
Rainfall
We used rainfall data from the Met Office [39]. We used
data from the Heathrow weather station (station ID: 708)
for 2016 and 2017. For the years 2013–2015, data from
Heathrow station is incomplete, so we used CHEAM P
STANO 2 (station ID: 6586), which is located near Sutton.
We obtained the total rainfall per day (for the 24-h period)
in mm.
Since rainfall in mmwas seen to be highly right-skewed,
we took the square root transformation.
Sunshine
We obtained data on daily duration of sunshine from the
Met Office [40].We used data fromHeathrow station (sta-
tion ID: 708). Sunshine duration is measured in hours.
There were 4 days in 2015 with missing observations, and
3 days in 2017 with missing observations. Observations
from Wattisham weather station in Suffolk (Station ID:
440) were used for these days.
Fig. 7 Distribution of the imputed partially observed logged step counts for each combination of year and arm. Imputed logged step counts for
M = 1 are shown for the four models considered
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Fig. 8 Distribution of the imputed missing logged step counts for each combination of year and arm. Logged step counts forM = 1 are shown for
the five models considered
Length of day
Length of day can be calculated by solar orbital
geometry. The daylength function in the R pack-
age geomsphere [41] is used to compute daylength
(photoperiod) for a given latitude and date. We used the
latitute for Bromley (51.4).
There were other weather variables available, such as
snowfall, hail, gale day, but these variables had a high
proportion of zeros. We did not use them as auxiliary
variables in our analysis.
MOVE-IT trial analysis: further results
We show further results from the analysis of the MOVE-
IT trial with the MI framework in this section.
Random effects
We display the random effects for the primary analysis
model in Table 3. The variances for the residuals are high-
est for individuals taking group therapy (arm 2), both
for year 1 and year 2, followed by the variances for the
residuals for those in usual care (arm 3). However, the
variance for the residuals in group therapy may be inflated
because there is a clustering of individuals who were in the
same therapy group which is not reflected in the model,
as it led to the model not converging. The covariances
between the observations in year 1 and year 2 is lowest for
arm 1.
Imputed step counts
We look at the distributions of the imputed logged step
counts. In Fig. 6, we display boxplots of the imputed
logged step counts for each combination of day of the
week, year and arm for the Plausible approach. We
observe that there is a weekend effect; the step counts
for Sunday, in particular, are generally lower than those
of weekdays. This effect is present across arms and also
across years.
We display the distribution of the imputed partially
observed logged step counts for each combination of year
and arm in Fig. 7 for M = 1. The boxplots are shown for
the four approaches which incorporate partially observed
data (the Dismissive approach does not). In Fig. 8, we plot
the boxplots for missing data for all five models. Corre-
sponding to the Forest plot in Fig. 4, we observe that the
imputed logged step counts are lower for the Suspicious
and Dismissivemodels.
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